 Neoplasm Recurrence, Local
"Neoplasm Recurrence, Local" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site.
| Descriptor ID |
D009364
|
| MeSH Number(s) |
C04.697.655 C23.550.727.655
|
| Concept/Terms |
Neoplasm Recurrence, Local- Neoplasm Recurrence, Local
- Local Neoplasm Recurrences
- Locoregional Neoplasm Recurrence
- Recurrences, Local Neoplasm
- Neoplasm Recurrences, Local
- Recurrence, Local Neoplasm
- Recurrence, Locoregional Neoplasm
- Local Neoplasm Recurrence
- Neoplasm Recurrence, Locoregional
- Locoregional Neoplasm Recurrences
- Neoplasm Recurrences, Locoregional
- Recurrences, Locoregional Neoplasm
|
Below are MeSH descriptors whose meaning is more general than "Neoplasm Recurrence, Local".
Below are MeSH descriptors whose meaning is more specific than "Neoplasm Recurrence, Local".
This graph shows the total number of publications written about "Neoplasm Recurrence, Local" by people in this website by year, and whether "Neoplasm Recurrence, Local" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1980 | 0 | 2 | 2 | | 1982 | 1 | 4 | 5 | | 1983 | 0 | 3 | 3 | | 1984 | 2 | 6 | 8 | | 1985 | 0 | 2 | 2 | | 1986 | 3 | 5 | 8 | | 1987 | 1 | 1 | 2 | | 1988 | 4 | 4 | 8 | | 1989 | 2 | 7 | 9 | | 1990 | 2 | 3 | 5 | | 1991 | 2 | 5 | 7 | | 1992 | 1 | 4 | 5 | | 1993 | 1 | 6 | 7 | | 1994 | 2 | 3 | 5 | | 1995 | 3 | 5 | 8 | | 1996 | 8 | 8 | 16 | | 1997 | 3 | 8 | 11 | | 1998 | 0 | 9 | 9 | | 1999 | 6 | 5 | 11 | | 2000 | 6 | 14 | 20 | | 2001 | 2 | 8 | 10 | | 2002 | 4 | 4 | 8 | | 2003 | 9 | 9 | 18 | | 2004 | 12 | 11 | 23 | | 2005 | 7 | 17 | 24 | | 2006 | 22 | 12 | 34 | | 2007 | 12 | 17 | 29 | | 2008 | 6 | 18 | 24 | | 2009 | 16 | 13 | 29 | | 2010 | 20 | 20 | 40 | | 2011 | 14 | 9 | 23 | | 2012 | 16 | 11 | 27 | | 2013 | 17 | 19 | 36 | | 2014 | 19 | 16 | 35 | | 2015 | 20 | 14 | 34 | | 2016 | 26 | 18 | 44 | | 2017 | 26 | 7 | 33 | | 2018 | 19 | 19 | 38 | | 2019 | 21 | 16 | 37 | | 2020 | 2 | 1 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Neoplasm Recurrence, Local" by people in Profiles.
-
Shelby RD, Suarez-Kelly LP, Yu PY, Hughes TM, Ethun CG, Tran TB, Poultsides G, King DM, Bedi M, Mogal H, Clarke C, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Krasnick BA, Fields RC, Pollock RE, Howard JH, Cardona K, Grignol V. Neoadjuvant radiation improves margin-negative resection rates in extremity sarcoma but not survival. J Surg Oncol. 2020 Jun; 121(8):1249-1258.
-
Abou-Alfa GK, Sahai V, Hollebecque A, Vaccaro G, Melisi D, Al-Rajabi R, Paulson AS, Borad MJ, Gallinson D, Murphy AG, Oh DY, Dotan E, Catenacci DV, Van Cutsem E, Ji T, Lihou CF, Zhen H, Féliz L, Vogel A. Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study. Lancet Oncol. 2020 05; 21(5):671-684.
-
Spiotto MT, Koshy M. The Risk Is Worth the Reward: Regional-Only Recurrence Is Curable with Nodal Dissection. Int J Radiat Oncol Biol Phys. 2020 02 01; 106(2):239-240.
-
Geoerger B, Kang HJ, Yalon-Oren M, Marshall LV, Vezina C, Pappo A, Laetsch TW, Petrilli AS, Ebinger M, Toporski J, Glade-Bender J, Nicholls W, Fox E, DuBois SG, Macy ME, Cohn SL, Pathiraja K, Diede SJ, Ebbinghaus S, Pinto N. Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1-2 trial. Lancet Oncol. 2020 01; 21(1):121-133.
-
Kurnit KC, Sinno AK, Fellman BM, Varghese A, Stone R, Sood AK, Gershenson DM, Schmeler KM, Malpica A, Fader AN, Frumovitz M. Effects of Gastrointestinal-Type Chemotherapy in Women With Ovarian Mucinous Carcinoma. Obstet Gynecol. 2019 12; 134(6):1253-1259.
-
Hammel P, Kindler HL, Reni M, Van Cutsem E, Macarulla T, Hall MJ, Park JO, Hochhauser D, Arnold D, Oh DY, Reinacher-Schick A, Tortora G, Algül H, O'Reilly EM, McGuinness D, Cui KY, Joo S, Yoo HK, Patel N, Golan T. Health-related quality of life in patients with a germline BRCA mutation and metastatic pancreatic cancer receiving maintenance olaparib. Ann Oncol. 2019 12 01; 30(12):1959-1968.
-
Zhang D, Gonzalez RS, Feely M, Umrau K, Lee H, Allende DS, Karamchandani DM, Zaleski M, Lin J, Westerhoff M, Zhang X, Alpert L, Liao X, Lai J, Liu X. Clinicopathologic features of Buschke-Löwenstein tumor: a multi-institutional analysis of 38 cases. Virchows Arch. 2020 Apr; 476(4):543-550.
-
Yao K, Belkora J, Lee C, Kuchta K, Pesce C, Kopkash K, Rabbitt S, Barrera E, Simovic S, Sepucha K. An In-Visit Decision Aid for Surgeons to Address Decision Making for Bilateral Mastectomy for Newly Diagnosed Breast Cancer Patients. Ann Surg Oncol. 2019 Dec; 26(13):4372-4380.
-
Mack JW, Cronin AM, Uno H, Shusterman S, Twist CJ, Bagatell R, Rosenberg A, Marachelian A, Granger MM, Glade Bender J, Baker JN, Park J, Cohn SL, Levine A, Taddei S, Diller LR. Unrealistic parental expectations for cure in poor-prognosis childhood cancer. Cancer. 2020 01 15; 126(2):416-424.
-
Banerjee I, Bozkurt S, Caswell-Jin JL, Kurian AW, Rubin DL. Natural Language Processing Approaches to Detect the Timeline of Metastatic Recurrence of Breast Cancer. JCO Clin Cancer Inform. 2019 10; 3:1-12.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|